Page last updated: 2024-08-23

cetylpyridinium chloride anhydrous and Acromegaly

cetylpyridinium chloride anhydrous has been researched along with Acromegaly in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chin, SO; Chung, CH; Chung, YS; Kim, BJ; Kim, HY; Kim, IJ; Kim, JG; Kim, MS; Kim, SW; Kim, SY; Lee, EJ; Lee, KY1

Other Studies

1 other study(ies) available for cetylpyridinium chloride anhydrous and Acromegaly

ArticleYear
Change in quality of life in patients with acromegaly after treatment with octreotide LAR: first application of AcroQoL in Korea.
    BMJ open, 2015, Jun-10, Volume: 5, Issue:6

    Topics: Acromegaly; Activities of Daily Living; Adult; Aged; Antineoplastic Agents, Hormonal; Female; Health; Health Status; Human Growth Hormone; Humans; Insulin-Like Growth Factor I; Male; Middle Aged; Octreotide; Outcome Assessment, Health Care; Physical Appearance, Body; Prospective Studies; Quality of Life; Republic of Korea; Surveys and Questionnaires; Young Adult

2015